tirzepatide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42618523
Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes.
Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes.
- 저자
- Mainak Banerjee, Ajitesh Roy, Vivek Mohan Sharma, Abhishek Das
- 저널
- Obesity (Silver Spring, Md.)
- 공개일
- 2026 Aug 19
- 연구 유형
- 기타
- DOI
- 10.1002/oby.70277
문헌 요약
This study aimed to compare the effectiveness of tirzepatide versus injectable semaglutide in preventing major adverse liver outcomes (MALO) among adults with overweight or obesity and type 2 diabetes. This retrospective target trial emulation utilized the TriNetX global network to analyze new users of tirzepatide and semaglutide. The primary outcome was…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.